Efficacy of Low-Dose Trimethoprim/Sulfamethoxazole for the Treatment of Pneumocystis jirovecii Pneumonia in Deceased Donor Kidney Recipients

BACKGROUND: Trimethoprim/sulfamethoxazole (TMP-SMX) is considered the first-choice treatment for Pneumocystis jirovecii pneumonia (PJP) in recipients of solid organ transplantation. However, this treatment is associated with various severe adverse events that might not be tolerable for some renal tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Jianlei, Wang, Qinghai, Huang, Tao, Wang, Ziyu, He, Pingli, Guo, Chen, Xu, Weijia, Cao, Yanwei, Dong, Zhen, Wang, Hongyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628180/
https://www.ncbi.nlm.nih.gov/pubmed/34853519
http://dx.doi.org/10.2147/IDR.S339622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628180/
https://www.ncbi.nlm.nih.gov/pubmed/34853519
http://dx.doi.org/10.2147/IDR.S339622

Ejemplares similares